Suzhou Zelgen Biopharmaceuticals Co Ltd Sustainability Reports
Suzhou Zelgen Biopharmaceuticals Co., Ltd. focuses on the research, development, manufacturing, and commercialization of innovative small molecule drugs, bispecific/trispecific antibodies, and complex recombinant proteins. Its clinical pipeline targets oncology, hematologic disorders, and autoimmune diseases.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG00PDZ49P1
1 reports from 2025 to 2025